AllRock Bio

Boston, United States

AllRock Bio is a drug developing firm that offers novel therapies to patients suffering hypertension and other fibrotic conditions.

$50.0M raised

Sep 2025

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has AllRock Bio raised?

AllRock Bio has raised $50.0M in total funding. The most recent round was Series A. The last funding was announced in September 2025.

Who are AllRock Bio's investors?

AllRock Bio's investors include Versant Ventures, Westlake Village BioPartners.

Where is AllRock Bio headquartered?

AllRock Bio is headquartered in Boston, United States.

What does AllRock Bio do?

AllRock Bio is a drug developing firm that offers novel therapies to patients suffering hypertension and other fibrotic conditions.

What stage is AllRock Bio at?

AllRock Bio is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 16, 2025.

MLA

"AllRock Bio — Funding & Investors." VCBacked, September 16, 2025, https://www.vcbacked.co/company/allrock-bio. Accessed July 2, 2026.

APA

VCBacked. (2025). AllRock Bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/allrock-bio

Wikipedia (cite web)

{{cite web |title=AllRock Bio — Funding & Investors |url=https://www.vcbacked.co/company/allrock-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 16, 2025.